Bernice Kwong, MD, clinical professor of dermatology, Stanford University, explains what dermatological considerations should be made for patients with leukemia and lymphoma.
Because patients with leukemia and lymphoma are immunocompromised, dermatologists need to look out for more infections and easily compromised skin integrity, explained Bernice Kwong, MD, clinical professor of dermatology, Stanford University.
Transcript
What dermatological considerations should be made regarding the management of patients with leukemia and lymphoma?
For leukemia and lymphoma, the patients are so immunocompromised from their disease already, it's a whole different flavor than our solid organ cancer patients who also have a lot of health issues of the same type. A patient with leukemia and lymphoma, by virtue of their disease, is probably immunocompromised already. When we add treatments onto that, we're going to be looking out for more infections. More infections are going to happen and their skin integrity is probably going to be more easily compromised.
Trying to acknowledge and balance all those things that can be contributing to poor skin healing or toxicity in the skin is really important just to know that their disease itself will manifest in a way that could cause skin problems already. Then, to compound treatments on top of that, we just have to be on a lookout for how even the toxicities from chemotherapies or anticancer agents that we have understood well in solid tumor patients are going to cause skin toxicity and a different flavor for our leukemia and lymphoma patients. Looking at the hosts and acknowledging that they are unique and different too, so that we can look at their skin from that lens, is important.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More